Ensuring a high-quality and resilient supply chain of essential medications means paying more.
J Manag Care Spec Pharm
; 28(5): 573-576, 2022 May.
Article
in English
| MEDLINE | ID: covidwho-1863467
ABSTRACT
DISCLOSURES Dr Mattingly reports consulting fees from Arnold Ventures, Pharmaceutical Research and Manufacturers of America, and research support from the US Food and Drug Administration unrelated to this article.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Drug Costs
/
Commerce
Limits:
Humans
Language:
English
Journal:
J Manag Care Spec Pharm
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS